Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure

NCT02862600 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of Efficacy

Conditions

Cardiomyopathy, Hypertrophic
Cardiomyopathy, Hypertrophic, Familial

Interventions

DRUG: Perhexiline
DEVICE: Use of bioanalytical assay to monitor plasma levels of perhexiline

Sponsor

Heart Metabolics Limited